A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies	Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Disease Progression, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, astrocytoma (excluding glioblastoma), colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, glioblastoma, glioma, intestinal disorder, lung cancer, lung disorder, lung neoplasm, malignant colon neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, neuroepithelial neoplasm, pancreas disorder, pancreatic neoplasm, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 1	2026-06-23		NCT04678648

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
RasCal Therapeutics, Inc.	1

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sarah Cannon, SCRI Oncology Partners	Nashville	United States	1
Sarah Cannon, SCRI Oncology Partners - Health One	Denver	United States	1
University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology	Los Angeles	United States	1